Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery
Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of Hemolink™ in combination with Intraoperative Autologous Donation
(IAD) versus control (IAD alone) in facilitating avoidance of allogeneic RBC transfusion
during and following primary CABG surgery